[1] Palsuledesai CC, Surviladze Z, Waller A, et al.Activation of Rho family GTPases by small molecules[J]. ACS Chem Biol, 2018, 13(6):1514-1524. [2] Peurois F, Peyroche G, Cherfils J, et al.Small GTPase peripheral binding to membranes:molecular determinants and supramolecular organization[J]. Biochem Soc Trans, 2019, 47(1):13-22. [3] Vega FM, Ridley AG.The RhoB small GTPase in physiology and disease[J]. Small GTPases, 2018, 9(5):384-393. [4] Ju JA, Gilkes DM.RhoB:Team oncogene or team tumor suppressor?[J]. Genes, 2018, 9(2):67. [5] Narumiya S, Thumkeo D.Rho signaling research:history, current status and future directions[J]. FEBS Lett, 2018, 592(11):1763-1776. [6] Nomikou E, Livitsanou M, Stournaras C, et al.Transcriptional and post-transcriptional regulation of the genes encoding the small GTPases RhoA, RhoB, and RhoC:implications for the pathogenesis of human diseases[J]. Cell Mol Life Sci, 2018, 75(12):2111-2124. [7] Mokady D, Meiri D.RhoGTPases-A novel link between cytoskeleton organization and cisplatin resistance[J]. Drug Resist Updat, 2015, 19:22-32. [8] Koi C, Izumi H, Kurita T, et al.Lovastatin induced Kruppel like factor 2(KLF2), Kruppel like factor 6(KLF6)and Ras homolog family member B(RHOB)genes and preferentially led to viability reduction of Cisplatin-resistant cells[J]. Oncotarget, 2017, 8(63):106429-106442. [9] Ahn J, Choi JH, Won M, et al.The activation of p38 MAPK primarily contributes to UV-induced RhoB expression by recruiting the c-Jun and p300 to the distal CCAAT box of the RhoB promoter[J]. Biochem biophys Res Commun, 2011, 409(2):211-216. [10] Wong VC.Nuclear EGFR and Integrator/Super Elongation Complex concurrently binds to Immediate Early Genes for gene transactivation[J]. J Cancer, 2018, 9(1):108-116. [11] Huang M, Satchell L, Duhadaway JB, et al.RhoB links PDGF signaling to cell migration by coordinating activation and localization of Cdc42 and Rac[J]. J Cell Biochem, 2011, 112(6):1572-1584. [12] Wei LJ, Li JA, Bai DM, et al.miR-223-RhoB signaling pathway regulates the proliferation and apoptosis of colon adenocarcinoma[J]. Chem Biol Interact, 2018, 289:9-14. [13] Marlow LA, Bok I, Smallridge RC, et al.RhoB upregulation leads to either apoptosis or cytostasis through differential target selection[J]. Endocr Relat Cancer, 2015, 22(5):777-792. [14] Ma Y, Gong Y, Cheng Z, et al.Critical functions of RhoB in support of glioblastoma tumorigenesis[J]. Neuro Oncol, 2015, 17(4):516-525. [15] Calvayrac O, Mazieres J, Figaro S, et al.The RAS-related GTPase RHOB confers resistance to EGFR-tyrosine kinase inhibitors in non-small-cell lung cancer via an AKT-dependent mechanism[J]. EMBO Mol Med, 2017, 9(2):238-250. [16] Yoneda M, Hirokawa YS, Ohashi A, et al.RhoB enhances migration and MMP1 expression of prostate cancer DU145[J]. Exp Mol Pathol, 2010, 88(1):90-95. [17] Chen W, Niu S, Ma X, et al.RhoB acts as a tumor suppressor that inhibits malignancy of clear cell renal cell carcinoma[J]. PLoS One, 2016, 11(7):e0157599. [18] Tan Y, Yin H, Zhang H, et al.Sp1-driven up-regulation of miR-19a decreases RHOB and promotes pancreatic cancer[J]. Oncotarget, 2015, 6(19):17391-17403. [19] Calvayrac O, Nowosad A, Cabantous S, et al.Cytoplasmic p27Kip1 promotes tumorigenesis via suppression of RhoB activity[J]. J Pathol, 2019, 247(1):60-71. [20] Zou O, Xiao X, Liang Y, et al.miR-19a-mediated downregulation of RhoB inhibits the dephosphorylation of AKT1 and induces osteosarcoma cell metastasis[J]. J Pathol, 2019, 247(1):60-71. [21] Kim BK, Kim HM, Chung KS, et al.Upregulation of RhoB via c-Jun N-terminal kinase signaling induces apoptosis of the human gastric carcinoma NUGC-3 cells treated with NSC12618[J]. Carcinogenesis, 2011, 32(3):254-261. [22] Cimbora-Zovko T, Fritz G, Mikac N, et al.Downregulation of RhoB GTPase confers resistance to cisplatin in human laryngeal carcinoma cells[J]. Cancer Lett, 2010, 295(2):182-190. |